We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
-3.15%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$68.1B
AUM Growth
-$6.46B
Cap. Flow
-$2.71B
Cap. Flow %
-3.98%
Top 10 Hldgs %
29.51%
Holding
3,234
New
60
Increased
712
Reduced
961
Closed
63

Top Buys

Rank Stock Value
1
SHEL icon
Shell
SHEL
+$58.6M
2
SCHW
Charles Schwab
SCHW
+$31.5M
3
SM icon
SM Energy
SM
+$30.4M
4
PBR icon
Petrobras
PBR
+$28.8M
5
NTES icon
NetEase
NTES
+$28.1M

Sector Composition

Rank Sector Weight
1 Technology 30.11%
2 Financials 14.58%
3 Healthcare 11.95%
4 Consumer Discretionary 10.52%
5 Industrials 8.85%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PAMT
2951
PAMT Corp
PAMT
$287M
$16.4K ﹤0.01%
1,352
AKYA
2952
DELISTED
Akoya BioSciences
AKYA
$16.4K ﹤0.01%
11,802
NNBR icon
2953
NN Inc
NNBR
$300M
$16.3K ﹤0.01%
7,200
UP icon
2954
Wheels Up
UP
$191M
$16.3K ﹤0.01%
805
INO icon
2955
Inovio Pharmaceuticals
INO
$76.1M
$16K ﹤0.01%
9,800
NKTX icon
2956
Nkarta
NKTX
$176M
$15.6K ﹤0.01%
8,455
AEYE icon
2957
AudioEye
AEYE
$73.2M
$15.5K ﹤0.01%
1,400
LXRX icon
2958
Lexicon Pharmaceuticals
LXRX
$1.07B
$15.5K ﹤0.01%
33,702
OBIO icon
2959
Orchestra BioMed
OBIO
$267M
$15.5K ﹤0.01%
3,623
ASPI icon
2960
ASP Isotopes
ASPI
$540M
$15.5K ﹤0.01%
3,300
GALT icon
2961
Galectin Therapeutics
GALT
$315M
$15.4K ﹤0.01%
12,600
CLPR
2962
Clipper Realty
CLPR
$47.2M
$15.3K ﹤0.01%
3,997
PROK icon
2963
ProKidney
PROK
$347M
$15.1K ﹤0.01%
17,179
CVGI icon
2964
Commercial Vehicle Group
CVGI
$134M
$14.7K ﹤0.01%
12,774
SVV icon
2965
Savers
SVV
$1.89B
$14.6K ﹤0.01%
2,119
CCCC icon
2966
C4 Therapeutics
CCCC
$400M
$14.6K ﹤0.01%
9,100
LXEO icon
2967
Lexeo Therapeutics
LXEO
$364M
$14.5K ﹤0.01%
4,187
AIP icon
2968
Arteris
AIP
$1.33B
$14.5K ﹤0.01%
2,100
EVGO icon
2969
EVgo
EVGO
$500M
$14.3K ﹤0.01%
5,373
-25,800
-83% -$79.9K
LRMR icon
2970
Larimar Therapeutics
LRMR
$417M
$14.2K ﹤0.01%
6,619
LZM icon
2971
Lifezone Metals
LZM
$364M
$14.2K ﹤0.01%
3,400
HLVX
2972
DELISTED
HilleVax
HLVX
$14.2K ﹤0.01%
9,799
RAPT
2973
DELISTED
RAPT Therapeutics
RAPT
$14.1K ﹤0.01%
1,444
AGEN
2974
Agenus
AGEN
$315M
$14K ﹤0.01%
9,331
IREN icon
2975
Iris Energy
IREN
$13.8B
$13.9K ﹤0.01%
+2,288
New +$22.3K

Similar funds

New York State Common Retirement Fund's Q1 2025 Portfolio in Review

As of Q1 2025, New York State Common Retirement Fund held 3,234 positions worth $68.1B, down 8.7% from $74.6B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

New York State Common Retirement Fund withdrew a net $2.71B in Q1 2025, closing 63 positions and reducing 961 holdings. Its most notable exit was Smartsheet Inc., an estimated $27.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 30% of assets, down from 33% a quarter earlier, followed by Financials and Healthcare.

Against the trend, New York State Common Retirement Fund opened a new position in Shell worth $63.7M.

  • New York State Common Retirement Fund's largest Q1 2025 buy was Shell: 869,549 shares worth $63.7M.
  • New York State Common Retirement Fund added most to Charles Schwab in Q1 2025, an estimated $31.5M increase.
  • New York State Common Retirement Fund's biggest Q1 2025 reduction was NVIDIA, cutting an estimated $193M.
  • New York State Common Retirement Fund fully exited Smartsheet Inc. in Q1 2025, selling an estimated $27.7M.
  • New York State Common Retirement Fund's ten largest holdings make up 30% of its $68.1B portfolio in Q1 2025.
  • New York State Common Retirement Fund opened 60 new positions and closed 63 in Q1 2025.
  • New York State Common Retirement Fund's portfolio value fell 8.7% quarter-over-quarter to $68.1B.

Based on New York State Common Retirement Fund's 13F filing for Q1 2025, filed 1 May 2025.